06.01.06
EcoNugenics, Santa Rosa, CA, has been issued U.S. Patent No. 7,026,302. This new patent protects the use of modified alginates and modified pectins in treating a wide range of diseases that may be caused or aggravated by heavy metals, environmental toxins or cholesterol. The diseases listed in the patent include arteriosclerosis, atherosclerosis, calcinosis, dermatomyositis, obesity, hypercholesterolemia and diabetes. EcoNugenics currently markets two products that are protected by this and earlier patents, 6,274,566 and 6,462,029.